355 related articles for article (PubMed ID: 34280359)
21. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
22. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
Wang H; Di X; Bi Y; Sun S; Wang T
Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
[TBL] [Abstract][Full Text] [Related]
24. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
26. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
Ni H; Ji D; Li J; Zhao Z; Zuo J
Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
[TBL] [Abstract][Full Text] [Related]
27. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
29. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
31. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway.
Ma H; Kong L; Liu L; Du Y; Zhu X; Wang J; Zhao W
Mol Carcinog; 2024 Jul; 63(7):1221-1234. PubMed ID: 38517039
[TBL] [Abstract][Full Text] [Related]
32. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
33. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
[TBL] [Abstract][Full Text] [Related]
34. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
[TBL] [Abstract][Full Text] [Related]
35. RBBP4 promotes colon cancer malignant progression
Li YD; Lv Z; Zhu WF
World J Gastroenterol; 2020 Sep; 26(35):5328-5342. PubMed ID: 32994691
[TBL] [Abstract][Full Text] [Related]
36. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
Ruiduo C; Ying D; Qiwei W
Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
[TBL] [Abstract][Full Text] [Related]
37. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
[TBL] [Abstract][Full Text] [Related]
39. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
[TBL] [Abstract][Full Text] [Related]
40. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]